ArticleAnnals of clinical and translational neurology2025

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High-Grade Gliomas: A Multicenter, Open-Label Phase I Study.

Zhuang Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.